Dutasteride improves QOL in benign prostatic hyperplasia

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.428, 2003-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dutasteride for the treatment of benign prostatic hyperplasia

By Wu Christopher Kapoor Anil

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1399-1408

Informa Healthcare

Access to resources Recommend Favorite

Dutasteride/Tamsulosin: In Benign Prostatic Hyperplasia

By Keating Gillian M.

Drugs & Aging, Vol. 29, Iss. 5, 2012-05 ,pp. : 405-419

Adis International

Access to resources Recommend Favorite

Dutasteride: a novel dual inhibitor of 5α-reductase for benign prostatic hyperplasia

By Djavan Bob Milani Shirin Fong Yan Kit

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 2, 2005-02 ,pp. : 311-317

Informa Healthcare

Access to resources Recommend Favorite

Dutasteride: a guide to its use as monotherapy in benign prostatic hyperplasia

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 24, Iss. 7, 2008-07 ,pp. : 5-9

Adis International

Access to resources Recommend Favorite

Combined medical treatment using dutasteride and tamsulosin for lower urinary tract symptoms suggestive of benign prostatic hyperplasia

By Djavan Bob Handl Markus Johannes Dianat Saeid

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2535-2547

Informa Healthcare

Access to resources Recommend Favorite